Peroxisome proliferator-activated receptor (PPAR)γ agonists, especially the representative compounds, thiazolidinediones (TZDs), alleviate hyperglycemia by effectively increasing glucose uptake and insulin sensitivity and improving insulin resistance [11,12,13]. The gene discussed is INS; the disease is Hyperglycemia.